![Shearwater Group Plc](/common/images/company/L_SWG.png)
A one-time dose of DURVEQTIX has reduced bleeds post-treatment compared to standard of care with a median annualized bleed rate (ABR) of zero bleeds (range 0 to 9.9) after up to four years of...
Giroctocogene fitelparvovec study meets primary and key secondary objectives of superiority compared to prophylaxis Pfizer Inc. (NYSE: PFE) today announced positive topline results from the Phase...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 4 | 9.41176470588 | 42.5 | 48 | 41 | 118826 | 46.43720061 | DE |
4 | 6.5 | 16.25 | 40 | 48 | 38.5 | 52647 | 44.03934467 | DE |
12 | 2.5 | 5.68181818182 | 44 | 48 | 38 | 28154 | 43.80392035 | DE |
26 | 3.5 | 8.13953488372 | 43 | 52.5 | 38 | 23347 | 44.82432992 | DE |
52 | 1 | 2.1978021978 | 45.5 | 53.5 | 33.5 | 27080 | 44.12257299 | DE |
156 | -116 | -71.3846153846 | 162.5 | 162.5 | 33.5 | 33757 | 92.10511464 | DE |
260 | -151 | -76.4556962025 | 197.5 | 295 | 1.55 | 246210 | 187.12777396 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.